CTLA4 and neoplasm: HPV-OPSCC has a different immunophenotype from HPV-negative HNSCC with increased T-cell infiltration, natural killer cells recruitment, PD-L1 and CTLA-4 expression, and higher tumor mutational burden [69] compared to HPV-negative tumors.